Widespread Decrease of Type 1 Cannabinoid Receptor Availability in Huntington Disease In Vivo

Abstract

The profound early and widespread reduction of CB1 availability in vivo is consistent with the hypothesis that mutant huntingtin represses CB1 transcription. This is the first, to our knowledge, in vivo demonstration of disturbance of the endocannabinoid system in a human neurologic disease.